Annotation Detail

Information
Associated Genes
TYMS
Associated Variants
TYMS 5' TANDEM REPEAT
TYMS 5' TANDEM REPEAT
Associated Disease
colorectal cancer
Source Database
CIViC Evidence
Description
The TYMS 5' 3TPR germline variant was significantly correlated with lower response to irinotecan plus 5-fluorouracil treatment in colorectal cancer patients. 149 metastatic CRC patients treated with irinotecan/5FU as first-line chemotherapy were followed in this study.
Variant Origin
germline
Variant Origin
Rare Germline
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/678
Gene URL
https://civic.genome.wustl.edu/links/genes/5971
Variant URL
https://civic.genome.wustl.edu/links/variants/265
Rating
3
Evidence Type
Predictive
Disease
Colorectal Cancer
Evidence Direction
Supports
Drug
Fluorouracil,Irinotecan
Evidence Level
B
Clinical Significance
Resistance
Pubmed
20628391
Drugs
Drug NameSensitivitySupported
FluorouracilResitance or Non-Reponsetrue
IrinotecanResitance or Non-Reponsetrue